United Microelectronics May Sales Soar 4% YoY: Details Here
UMC reports a 3.89% YoY increase in May sales, amid plans for a Singapore facility and unveiling groundbreaking 3D IC technology.
Boeing’s Outgoing CEO Dave Calhoun Set To Testify Before US Senate On June 18 Amid Safety Concerns
he hearing will cover a range of issues, including the FAA's decision to halt the production of the 737 MAX after a door panel malfunctioned on a flight operated by Alaska Airlines in January.
Lululemon +8% On Thursday: What’s Going On?
Lululemon's shares surge in premarket trading following its first-quarter earnings report, which revealed strong comparable sales growth and plans for international expansion, despite concerns over the recent departure of its product chief to Vans, V.F. Corporation's struggling brand.
Microsoft Under FTC Investigation For Inflection AI Acquisition Strategy: Report
Microsoft Corp. is reportedly under FTC scrutiny for its $650 million deal with Inflection AI. The FTC is investigating if Microsoft designed the agreement to bypass antitrust review, potentially leading to fines and suspension of the deal. This investigation is part of the FTC's broader effort to monitor AI investments by major tech companies.
Dan Niles Predicts ‘So Much More Growth’ For Nvidia As Jensen Huang-Led Tech Giant Surpasses Apple: ‘If I Have To Pick One To Own For The Next Couple Of Years…’
Niles highlighted that Apple had been a "massive underperformed" with dropping revenues while Nvidia revenue is on a climb.
Amid FTC Probe, Meta In Hot Waters With EU With 11 Privacy Complaints Over AI Data Use
The complaints were submitted by the advocacy group NOYB (None Of Your Business) to prompt national privacy watchdogs to intervene and halt Meta's intended use of personal data.
‘Trump Georgia Election Case Halted Pending Outcome Of Challenge To D.A.’ – CNBC
https://www.cnbc.com/2024/06/05/trump-georgia-election-case-halted-pending-outcome-of-challenge-to-da.htmlA Georgia appeals court put on hold the criminal election case against former President Donald Trump in that
Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts
Analysts foresee Bath & Body Works' second-half performance improving, citing strength in product innovation and category expansion, despite inventory uptick in Q1 FY24.
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
Amgen announced Phase 3 trial results for Uplizna for IgG4-related disease, achieving an 87% reduction in flare risk. All key secondary endpoints were met with no new safety signals.
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.